Marker Therapeutics Ownership | Who Owns Marker Therapeutics?


OverviewForecastRevenueFinancialsChart

Marker Therapeutics Ownership Summary


Marker Therapeutics is owned by 24.55% institutional investors, 7.08% insiders, and 68.37% retail investors. Nea management company is the largest institutional shareholder, holding 11.65% of MRKR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.61% of its assets in Marker Therapeutics shares.

MRKR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMarker Therapeutics24.55%7.08%68.37%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nea management company1.63M11.65%$1.45M
Blue owl capital lp554.25K3.97%$494.72K
Aisling capital management lp325.37K2.33%$290.43K
Vanguard group299.78K2.15%$267.70K
Renaissance106.25K0.76%$94.84K
Geode capital management96.32K0.69%$85.99K
Advisor group81.08K0.58%$74.23K
Lpl financial58.75K0.42%$52.44K
Two sigma securities47.60K0.34%$42.49K
Two sigma investments, lp36.54K0.26%$32.62K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blue owl capital lp554.25K0.15%$494.72K
Nea management company1.63M0.08%$1.45M
Aisling capital management lp325.37K0.06%$290.43K
Two sigma securities47.60K0.01%$42.49K
Virtu financial28.33K0.00%$25.00K
Matrix asset advisors inc/ny15.00K0.00%$13.39K
Xtx topco21.77K0.00%$19.43K
Ashton thomas private wealth10.00K0.00%$8.93K
Renaissance106.25K0.00%$94.84K
Advisor group81.08K0.00%$74.23K

Top Buyers

HolderShares% AssetsChange
Advisor group81.08K0.00%61.50K
Two sigma securities47.60K0.01%47.60K
Renaissance106.25K0.00%36.81K
Two sigma investments, lp36.54K-36.54K
Virtu financial28.33K0.00%28.33K

Top Sellers

HolderShares% AssetsChange
Hudson bay capital management lp---499.73K
Alyeska investment group---213.02K
Ar asset management---73.70K
Squarepoint ops---43.30K
Jane street group---21.80K

New Positions

HolderShares% AssetsChangeValue
Two sigma securities47.60K0.01%47.60K$42.49K
Two sigma investments, lp36.54K-36.54K$32.62K
Virtu financial28.33K0.00%28.33K$25.00K
Xtx topco21.77K0.00%21.77K$19.43K
Ashton thomas private wealth10.00K0.00%10.00K$8.93K

Sold Out

HolderChange
Riggs asset managment-1.20K
Tower research capital llc (trc)-3.38K
Raymond james financial-9.52K
Dimensional fund advisors lp-15.90K
Jane street group-21.80K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202531-3,426,3710.47%242.60%1645.45%3-50.00%
Jun 30, 202530-3.23%3,379,937-17.03%302.26%9-25.00%716.67%
Mar 31, 20251-73,700--97.29%----
Dec 31, 20241-73,700--121.08%--100.00%--
Sep 30, 20241-73,7004.24%-130.95%1---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv181.72K1.61%-3.97K
Vanguard US Total Market Shares ETF153.47K1.43%-
Vanguard Institutional Extnd Mkt Idx Tr88.27K0.78%1.13K
Fidelity Extended Market Index47.41K0.37%-334.00
WEALTHGATE Biotech Aggressive Fund I25.44K0.29%-
Vifag 2002 SICAV30.00K0.23%-
DFA US Small Cap I15.90K0.14%-
iShares Micro-Cap ETF12.60K0.11%-
Fidelity Series Total Market Index13.89K0.11%-
Fidelity Total Market Index12.81K0.10%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 23, 2024ELMS STEVE-Buy$35.47K
Dec 23, 2024New Enterprise Associates 16, L.P.-Buy$1.77M
Mar 16, 2021Eansor Norman David-Buy$249.99K
May 18, 2021Wasserman Frederick Gerald-Buy$24.10K
Mar 16, 2021Walker Paul Edward-Buy$10.00M

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q1--
2024 Q42-
2023 Q2--
2023 Q1--

MRKR Ownership FAQ


Who Owns Marker Therapeutics?

Marker Therapeutics shareholders are primarily institutional investors at 24.55%, followed by 7.08% insiders and 68.37% retail investors. The average institutional ownership in Marker Therapeutics's industry, Biotech Stocks , is 45.24%, which Marker Therapeutics falls below.

Who owns the most shares of Marker Therapeutics?

Marker Therapeutics’s largest shareholders are Nea management company (1.63M shares, 11.65%), Blue owl capital lp (554.25K shares, 3.97%), and Aisling capital management lp (325.37K shares, 2.33%). Together, they hold 17.95% of Marker Therapeutics’s total shares outstanding.

Does Blackrock own Marker Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Marker Therapeutics.

Who is Marker Therapeutics’s biggest shareholder by percentage of total assets invested?

Blue owl capital lp is Marker Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.15% of its assets in 554.25K Marker Therapeutics shares, valued at 494.72K$.

Who is the top mutual fund holder of Marker Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Marker Therapeutics shares, with 1.61% of its total shares outstanding invested in 181.72K Marker Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools